HIGHLIGHTS
- who: Claudia Mosillo et al. from the , Terni, Italy have published the research work: Targeted Approaches in Metastatic Castration-Resistant Prostate Cancer: Which Data?, in the Journal: Cancers 2022, 14, 4189. of /2022/
- what: The aim of this review is to summarize and discuss the present results of new molecular targeted approaches for mCRPC. Of this study demonstrated a promising antitumor activity with durable disease control, particularly in patients with HRD (ORR 33% in the overall population and 88% in HRD population-rPFS 0.7 months in the overall population and 9.8 months in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.